N-(三苯基甲基)-5-(4'-甲基联苯-2-基)四氮唑 | 124750-53-4
N-(三苯基甲基)-5-(4'-甲基联苯-2-基)四氮唑
5-(4'-Methyl-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole
124750-53-4
C33H26N4
478.58634
名称和标识符
MDL |
MFCD00665220 |
InChIKey |
ZSBYTGRKIKIRRJ-UHFFFAOYSA-N |
Inchi |
1S/C33H26N4/c1-25-21-23-26(24-22-25)30-19-11-12-20-31(30)32-34-35-36-37(32)33(27-13-5-2-6-14-27,28-15-7-3-8-16-28)29-17-9-4-10-18-29/h2-24H,1H3 |
SMILES |
CC1=CC=C(C2=CC=CC=C2C3=NN=NN3C(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)C=C1 |
别名信息
- 中文别名 -
- N-(三苯基甲基)-5-(4'-甲基联苯-2-基)四氮唑
- 5-(4’-甲基联苯-2-基)-1-三苯基甲基四氮唑
- 5-[4鈥?-Methyl (1,1鈥?-biphenyl)-2-yl]-1-triphenylmethyl-tetrazole
- N-(三苯基甲基)-5-(4’-甲基联苯-2-基)四氮唑
- N-(三苯基甲基)-5-(4''-甲基联苯-2-基)四氮唑
- N-(三苯基甲基)-5-(4'-甲基联苯-2-基)四氮唑 TTMB
- N-(三苯基甲基)-5-(4'-甲基联苯-2-基)四氮唑(TTMB)
- N-三苯基甲基-5-(4'-甲基联苯-2-基)四氮唑
- β-环糊精吡罗昔康
- 氯沙坦杂质
- 5-(4-甲基联苯-2-基)-1-三苯甲基-1H-四氮唑
- N-(三苯基甲基)-5-(4`-甲基联苯-2-基)四氮唑
- 三苯甲基四氮唑
- 英文别名 -
- 5-(4'-Methyl-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole
- N-(Triphenylmethyl)-5-(4'-MethylBiphenyl-2-yl-) Tetrazole
- 5-(4'-Methyl-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole
- 5-(4'-METHYLBIPHENYL-2-YL)-1-TRITYL-1H-TETRAZOLE
- 5-[2-(4-methylphenyl)phenyl]-1-trityltetrazole
- EnterpriseStandard
- TTMB
- ACMC-1BYOC
- AG-D-52604
- CTK0H4515
- Jsp001626
- N-(Triphenylmethyl)-5-(4'-Methylbiphenyl-2-yl) Tetrazole
- PubChem9043
- SureCN635
- N-(Triphenylmethyl)-5-(4'-methylbiphenyl-2-yl-)terazole
- BCP25559
- CS-0153067
- 1-(2-benzhydrylphenyl)-5-[2-(p-tolyl)phenyl]tetrazole
- 5-(4'-Methyl-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole
- N-(Triphenylmethyl)-5-(4'-methylbiphenyl-2-yl-)tetrazole (TTMB)
- N-TRIPHENYLMETHYL-5-(4'-METHYLBIPHENYL-2-YL) TETRAZOLE
- ZSBYTGRKIKIRRJ-UHFFFAOYSA-N
- SCHEMBL635
- 4-Methyl-2'-(triphenylmethyltetrazol-5-yl)biphenyl
- A805289
- 9QV2ZKZ95S
- O11294
- AKOS000278515
- MFCD00665220
- 2-(Triphenylmethyltetrazol-5-yl)-4'-methylbiphenyl
- 5-[4'-Methyl (1,1'-biphenyl)-2-yl]-1-triphenylmethyl-tetrazole
- J-516266
- N-(?????)-5-(4,-????-2-?) ?
- 5-(4'-Methyl[1,1'-biphenyl]-2-yl)-1-(triphenylmethyl)-1H-tetrazole
- Tetrazole, 5-(4'-methyl[1,1'-biphenyl]-2-yl)(triphenylmethyl)-
- 5-(4'-Methyl-[1 pound not1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole
- N-(Triphenylmethyl)-5-(4'-methylbiphenyl-2-yl-)tetrazole
- 5-(4-Methylbiphenyl-2-yl)-1-trityl-1H-tetrazole
- N-Triphenylmethyl-5-[4'-methylbiphenyl-2-yl] tetrazole
- DTXSID20436185
- Losartan Impurity 5-(4'-Methyl-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole
- 1H-Tetrazole, 5-(4'-methyl[1,1'-biphenyl]-2-yl)-1-(triphenylmethyl)-
- 124750-53-4
- FT-0656612
- 4-Methyl-2'-(N-triphenylmethyl-(1H-tetrazol-5-yl))biphenyl
- C33H26N4
物化性质
实验特性
LogP |
7.15570 |
PSA |
43.60000 |
折射率 |
1.645 |
沸点 |
681.6°C at 760 mmHg |
闪点 |
366.038 °C |
密度 |
1.136 |
计算特性
精确分子量 |
478.21600 |
氢键供体数量 |
0 |
氢键受体数量 |
4 |
可旋转化学键数量 |
6 |
同位素质量 |
478.21574685g/mol |
重原子数量 |
37 |
复杂度 |
639 |
同位素原子数量 |
0 |
确定原子立构中心数量 |
0 |
不确定原子立构中心数量 |
0 |
确定化学键立构中心数量 |
0 |
不确定化学键立构中心数量 |
0 |
共价键单元数量 |
1 |
疏水参数计算参考值(XlogP) |
8 |
拓扑分子极性表面积 |
43.6Ų |